Profitability This table compares BioLargo and Global Partner Acquisition Corp II's net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets BioLargo -11.45% -39.90% -22.06% Global Partner Acquisition Corp II N/A -0.90% -8.69% Volatility and Risk BioLargo has a beta of -0.11, meaning that its stock price is
BioLargo, Inc. (OTCQX:BLGO) Q3 2025 Earnings Call November 14, 2025 4:30 PM EST Company Participants Dennis Calvert - Chairman, President & CEO Dennis Calvert - Chief Financial Officer Conference Call Participants Brian Loper Presentation Operator Good day, everyone. Welcome to the BioLargo Q3 Earnings Results Conference Call.
BioLargo, Inc. (OTCQX:BLGO) Q4 2024 Earnings Conference Call March 31, 2025 4:00 PM ET Company Participants Brian Loper - Investor Relations Dennis Calvert - Chief Executive Officer Charlie Dargan - Chief Financial Officer Conference Call Participants Operator Good day, everyone, and welcome to the BioLargo Annual 2024 Earnings Results. At this time, all participants have been placed on a listen-only mode.
| Chemicals Industry | Materials Sector | Dennis Calvert CEO | OTCQB Exchange | 09065A100 CUSIP |
| US Country | 40 Employees | - Last Dividend | 21 Mar 2007 Last Split | - IPO Date |
BioLargo, Inc. is a dynamic player in the environmental technologies sector, focusing on the invention, development, and commercialization of solutions aimed at addressing some of the most pressing environmental challenges. Founded in 1991 and headquartered in Westminster, California, this innovator targets problems related to water contamination, especially with harmful compounds like per- and polyfluoroalkyl substances (PFAS), and extends its solutions to advanced water and wastewater treatment. Besides water treatment, BioLargo tackles industrial odor management, volatile organic compounds control, air quality enhancement, and infection prevention, contributing to significant environmental remediation efforts. The company’s comprehensive approach is highlighted by its provision of full-service environmental engineering services, positioning BioLargo as a key contributor to environmental health and safety.
BioLargo specializes in addressing water contamination by per- and polyfluoroalkyl substances (PFAS), offering leading-edge technology designed to remove these harmful chemicals from water sources. This service is critical for ensuring safe drinking water and maintaining ecosystem health.
The company provides technologies and solutions for advanced water and wastewater treatment, leveraging innovative processes to purify water, making it safe for consumption and release into the environment. These solutions cater to both industrial and municipal needs.
With an emphasis on improving air quality, BioLargo offers solutions for controlling industrial odors and reducing volatile organic compounds (VOCs). These technologies are crucial for industries looking to mitigate air pollution and ensure regulatory compliance.
To further enhance environmental wellness, BioLargo develops systems aimed at air quality control. These innovations help in reducing airborne pollutants, thus contributing to healthier living and working spaces.
Recognizing the importance of preventing infections in both humans and animals, BioLargo offers technologies designed for infection control. This includes solutions that eradicate pathogens and reduce the risk of disease spread, benefiting public health sectors and industries alike.
The comprehensive suite of services extends to environmental remediation, where BioLargo’s expertise is utilized to repair and restore environments contaminated or damaged by pollutants. This service is integral to the maintenance and recovery of natural habitats.
Besides its product offerings, BioLargo provides full-service environmental engineering services, encompassing consultation, design, implementation, and management of environmental projects. This end-to-end approach ensures clients receive tailored solutions that meet their specific environmental challenges.